385547003: Ibritumomab tiuxetan 3.2mg injection solution 2mL vial (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1459726011 Ibritumomab tiuxetan 3.2mg injection solution 2mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1479752018 Ibritumomab tiuxetan 3.2mg injection solution 2mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1491139011 Ibritumomab tiuxetan 3.2mg injection 2mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1459726011 Ibritumomab tiuxetan 3.2mg injection solution 2mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1479752018 Ibritumomab tiuxetan 3.2mg injection solution 2mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1491139011 Ibritumomab tiuxetan 3.2mg injection 2mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	Is a	Product containing ibritumomab tiuxetan (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ibritumomab tiuxetan (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	Is a	Ibritumomab tiuxetan	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Antineoplastic agent (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	Has manufactured dose form	Injection (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial	Is a	Product containing ibritumomab tiuxetan (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

SAME AS association reference set (foundation metadata concept)